FDA Adverse Event Malfunction Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1913336 · Received November 11, 2010

Report

Report Number
2024168-2010-02429
Event Type
Malfunction
Date Received
November 11, 2010
Date of Event
October 19, 2010
Report Date
October 21, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). STENT DISLODGEMENT CAN BE INFLUENCED BY MANY FACTORS, INCLUDING, BUT NOT LIMITED TO: IMPROPER OR INADEQUATE CRIMPING AT THE TIME OF MANUFACTURE, INCORRECT SHEATH SIZING, POSITIVE PRESSURE DURING PREPARATION, NEGATIVE PRESSURE DURING SHEATH REMOVAL, FORCED SHEATH REMOVAL, HANDLING OF THE STENT DURING PREPARATION, AND INTERACTION WITH THE LESION AND/OR ACCESSORY DEVICES. THERE WAS NO REPORT OF ANY DAMAGE TO THE STENT DELIVERY SYSTEM OR STENT IMPLANT PRIOR TO USE, SUGGESTING THAT THE STENT DISLODGEMENT MAY HAVE BEEN A RESULT OF THE PROCEDURE. ALTHOUGH A CONCLUSIVE CAUSE CANNOT BE DETERMINED FOR THE REPORTED STENT DISLODGEMENT, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT THERE WAS A STENT DISLODGEMENT, HOWEVER; THERE WAS NO REPORTED PT INJURY. THE PHYSICIAN DID NOT RECALL ANY SPECIFIC CASE DETAILS, AND REFUSED TO OBTAIN THE INFO. THE ACCOUNT REP WENT INTO THE CATH LAB TO TRY AND GET FURTHER INFO. THE CATH LAB STAFF DID NOT RECALL AND DID NOT WANT TO LOOK INTO THIS ISSUE TO OBTAIN INFO FOR REP. NO FURTHER INFO IS AVAILABLE ON THIS EVENT. YOU ARE RECEIVING THIS MDR REPORT FROM ABBOTT VASCULAR BECAUSE BOSTON SCIENTIFIC CORPORATION DISTRIBUTES PROMUS AS ITS OWN BRAND LABELING OF ABBOTT VASCULAR'S DRUG ELUTING STENT IN THE UNITED STATES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA UNK

Patients

Seq Age Sex Outcome Treatment
1